Visual summary
Integrate LM architecture, IF immune pattern, and EM location with the clinical syndrome; then ask what is active, chronic, and treatable.
Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.
Diagram description
Three views of the same tissue answer different questions. . Drawings are schematic, not diagnostic micrographs. Adequacy and clinical context change interpretation. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.
Text version
Ask the clinical question first
Record protein burden, sediment, kidney-function trajectory, serologies, systemic findings, and relevant medicines. Biopsy should resolve a diagnosis or treatment uncertainty. A sample without the clinical question can yield a correct description but an incomplete clinical interpretation.
Light microscopy: pattern and damage
Look for mesangial/endocapillary proliferation, necrosis, crescents, segmental sclerosis, thrombi, and interstitial inflammation. Cellular lesions can represent activity; global sclerosis and interstitial fibrosis/tubular atrophy indicate chronic damage. The amount of each matters more than a disease label alone.
Immunofluorescence: organize the mechanism
Linear GBM IgG suggests anti-GBM disease; granular deposits suggest immune complexes; sparse staining with necrotizing crescents suggests pauci-immune GN. Check immunoglobulins, complement, kappa/lambda, and distribution. Full-house staining supports lupus in context but is not pathognomonic.
Electron microscopy: locate the lesion
Subepithelial deposits support a membranous pattern; subendothelial deposits often accompany inflammation; mesangial deposits suggest a different distribution. Diffuse foot-process effacement signals podocyte injury but occurs in multiple diseases. Organized deposits may require a monoclonal-protein evaluation.
Adequacy changes confidence
Confirm cortical tissue and allocation for LM, IF, and EM. Focal disease such as FSGS can be missed in a small sample; medulla alone cannot characterize glomerular disease. An inadequate negative result is not evidence that the suspected lesion is absent.
Translate into the next decision
Synthetic example: crescents with little IF staining plus compatible MPO-ANCA suggests a different pathway from crescents with linear IgG and anti-GBM antibodies. Discuss discordance with the pathologist. Avoid predicting a precise recovery percentage from a chronicity score alone.
